Isturisa 1 mg film-coated tablets, Isturisa 5 mg film-coated tablets, Isturisa 10 mg film-coated tablets
CLCI699C2203
Phase 2 small_molecule active
Quick answer
Isturisa 1 mg film-coated tablets, Isturisa 5 mg film-coated tablets, Isturisa 10 mg film-coated tablets for Cushing's disease is a Phase 2 program (small_molecule) at Recordati Ireland with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Recordati Ireland
- Indication
- Cushing's disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active